NEW YORK, Jan. 27, 2020 /PRNewswire/ -- Bernstein
Liebhard, a nationally acclaimed investor rights law firm, is
investigating potential securities fraud claims on behalf of
shareholders of Portola Pharmaceuticals, Inc. ("Portola" or the
"Company") (NASDAQ: PTLA) from allegations that Portola might have
issued misleading information to the investing public.
If you purchased Portola securities, and/or would like to
discuss your legal rights and options please visit Portola
Shareholder Investigation or contact Matthew E. Guarnero toll free at (877)
779-1414 or MGuarnero@bernlieb.com.
On January 10, 2020 Portola
announced that its preliminary fourth quarter revenue from its drug
Andexxa, an antidote for patients treated with anticoagulants,
would only be approximately $28
million which was well below the $39
million estimate and $41
million consensus. Portola attributed the performance in
part to cost-cutting at hospitals noting that "hospital pharmacies
curtailed use of Andexxa following drug utilization reviews in an
effort to manage pharmacy budgets."
On this news, shares of Portola dropped precipitously during
intra-day trading on January 10,
2020.
If you purchased Portola securities, and/or would like to
discuss your legal rights and options please visit
https://www.bernlieb.com/cases/portolapharmaceuticalsinc-ptla-shareholder-class-action-lawsuit-stock-fraud-239/apply/
or contact Matthew E. Guarnero toll
free at (877) 779-1414 or MGuarnero@bernlieb.com.
Since 1993, Bernstein Liebhard LLP has recovered over
$3.5 billion for its clients. In
addition to representing individual investors, the Firm has been
retained by some of the largest public and private pension funds in
the country to monitor their assets and pursue litigation on their
behalf. As a result of its success litigating hundreds of lawsuits
and class actions, the Firm has been named to The National
Law Journal's "Plaintiffs' Hot List" thirteen times and
listed in The Legal 500 for ten consecutive
years.
ATTORNEY ADVERTISING. © 2020 Bernstein Liebhard LLP. The law
firm responsible for this advertisement is Bernstein Liebhard LLP,
10 East 40th Street, New York, New
York 10016, (212) 779-1414. The lawyer responsible for this
advertisement in the State of
Connecticut is Michael S. Bigin. Prior results do not
guarantee or predict a similar outcome with respect to any future
matter.
Contact Information
Matthew E. Guarnero
Bernstein Liebhard LLP
https://www.bernlieb.com
(877) 779-1414
MGuarnero@bernlieb.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/ptla-losses-alert-bernstein-liebhard-llp-reminds-investors-of-its-investigation-into-portola-pharmaceuticals-inc-and-encourages-investors-with-losses-to-contact-the-firm-300993681.html
SOURCE Bernstein Liebhard LLP